microdose glp 1 results GLP-1 microdosing is popular, but there's little evidence it works Microdosing GLP-1s: Risks & Considerations

By improving blood sugar stability and slowing digestion, GLP-1 therapy makes sustainable, long-term weight loss more achievable especially when combined with personalized medical guidance

A number needed to treat of 66 to prevent a MACE event is competitive with many of our most established cardiovascular therapies

For example, a May 2024 issue brief released by Blue Health Intelligence (BHI) for the Blue Cross Blue Shield Association evaluated members with employer-based Blue Cross Blue Shield health insurance coverage and found that about 60% of those taking GLP-1 medications for weight loss discontinued use before seeing a clinical benefit

This distinction is central to their defense